# Erythrocin Lactobionate

NDC: 0409-6482
Generic name: ERYTHROMYCIN LACTOBIONATE
Labeler / Manufacturer: Hospira, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20050525

FDA application: NDA050609

## Active ingredients

- ERYTHROMYCIN LACTOBIONATE: 500 mg/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0409-6482"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0409-6482
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a96c405f-bd70-4bb4-719e-ac6a79dcc213